Press release
Polymyalgia Rheumatica Market to Hit $322.49 Mn by 2034
The global healthcare industry is increasingly focused on addressing chronic inflammatory conditions, among which polymyalgia rheumatica (PMR) holds a distinct place. Primarily affecting individuals over the age of 50, PMR is characterized by pain and stiffness in the shoulders and hips, often linked to systemic inflammation. According to Expert Market Research, the global polymyalgia rheumatica treatment market attained a value of USD 203.73 million in 2024 and is expected to grow at a CAGR of 4.70% between 2025 and 2034, reaching nearly USD 322.49 million by 2034.Polymyalgia Rheumatica Treatment Market Share
The market is shaped by both geographical and product-based segmentations. North America currently leads in terms of market share, driven by a high prevalence of PMR among the aging population, advanced diagnostic infrastructure, and robust healthcare expenditure. Europe also represents a significant share, especially in countries with a high geriatric population such as Germany and the United Kingdom. Meanwhile, the Asia Pacific region is witnessing rising diagnosis rates due to increased healthcare awareness and improved access to treatment options.
In terms of drug classes, corticosteroids dominate the market due to their effectiveness in rapidly reducing inflammation and alleviating symptoms. Hospitals remain the primary end-users, owing to the need for comprehensive diagnostic evaluation and long-term care.
Get a Free Sample Report with Table of Contents - https://surl.li/cfxyge
Polymyalgia Rheumatica Treatment Market Growth & Trends
Several factors are driving the growth of this niche but critical segment of the pharmaceutical industry:
Aging Global Population: PMR predominantly affects older adults. With global life expectancy on the rise, the at-risk demographic continues to expand, especially in developed and aging nations.
Improved Diagnostic Accuracy: The increasing availability of imaging technologies such as ultrasound and MRI has improved early diagnosis and disease differentiation, thereby facilitating timely treatment.
Patient-Centric Care Models: There is a growing emphasis on homecare and specialty clinic services, particularly in developed countries, where patient convenience and personalized care are prioritized.
Therapeutic Advances: New studies exploring biologic DMARDs (disease-modifying anti-rheumatic drugs) offer potential to shift the treatment landscape beyond corticosteroids, especially in steroid-resistant or relapsing cases.
Increased Awareness: Public health campaigns and clinician education have led to earlier identification of symptoms and increased referrals for rheumatologic evaluation.
According to Wikipedia, the underlying cause of polymyalgia rheumatica remains unclear, but its strong association with temporal arteritis continues to motivate research into shared inflammatory pathways.
Polymyalgia Rheumatica Treatment Market Case Studies & News
Recent developments in the polymyalgia rheumatica treatment space have centered around drug approvals and partnerships:
Horizon Therapeutics plc has initiated exploratory trials to assess targeted anti-inflammatory drugs for PMR and associated autoimmune conditions.
Sanofi SA continues to expand its corticosteroid product offerings globally, particularly in oral formulations suitable for long-term use in chronic conditions.
AbbVie Inc. has ramped up its biologics research platform, exploring novel DMARDs that may prove effective for PMR patients with coexisting rheumatologic conditions.
GlaxoSmithKline has partnered with academic centers to investigate early biomarkers for inflammatory diseases, including PMR.
These developments point toward a growing industry focus on more sustainable and safer long-term treatments, especially given the risks associated with prolonged steroid use.
Polymyalgia Rheumatica Treatment Market Analysis
The PMR treatment market is moderately consolidated, with a few major players holding significant shares due to their robust product pipelines and global distribution capabilities. Pricing strategies, regulatory approvals, and regional expansion are among the key competitive differentiators.
Regional Insights:
North America: Leads the market due to high disease awareness, availability of diagnostic tools, and government-supported elderly care programs.
Europe: Strong pharmaceutical R&D presence and favorable reimbursement frameworks support treatment uptake.
Asia Pacific: Emerging market with increasing diagnosis rates and growing investment in chronic disease management.
Latin America & Middle East and Africa: Smaller market size but significant long-term potential due to improving healthcare systems and increasing geriatric populations.
Read the Full Report with the Table of Contents - https://surl.li/tavljr
Polymyalgia Rheumatica Treatment Market Segmentation
By Diagnostic Method:
Blood Tests
Imaging Tests
By Drug Class:
Corticosteroids
Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Others
By Route of Administration:
Oral
Parenteral
By End Use:
Hospitals
Homecare
Speciality Clinics
Others
By Region:
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
This segmentation allows healthcare stakeholders to identify where demand is concentrated and tailor service delivery and product development accordingly.
Key Players in the Polymyalgia Rheumatica Treatment Market
Major players operating in this market include:
Sanofi SA
Apotex Corporation
GlaxoSmithKline plc
AbbVie Inc.
Horizon Therapeutics plc
Others
These companies are actively involved in expanding their product portfolios, conducting clinical trials, and forming collaborations to advance research in inflammatory conditions like PMR.
Find More Reports
North America Hemoglobinopathies Market - https://shorturl.at/Nnk0G
North America Breast Implants Market - https://shorturl.at/xGC7f
North America Clinical Trials Market - https://shorturl.at/W7kuv
India Disposable Medical Gloves Market - https://shorturl.at/72r3Y
CDMO Market Size - https://shorturl.at/7c1ES
Media Contact
Company Name: Claight Corporation
Contact Person: Roshan Kumar, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
About Us
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analysis provides the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today's competitive market.
Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organization's future success by acquiring one of our Expert Market Research reports today.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Polymyalgia Rheumatica Market to Hit $322.49 Mn by 2034 here
News-ID: 4125698 • Views: …
More Releases from Expert Market Research

Lung Cancer Therapeutics Market to Hit USD 95.65 Bn by 2034
The treatment landscape for lung cancer continues to evolve, driven by a combination of scientific breakthroughs, growing global incidence, and an urgent need for more effective therapies. According to Expert Market Research, the global lung cancer therapeutics market attained a value of USD 31.92 billion in 2024. It is projected to grow at a CAGR of 11.60% during the forecast period of 2025 to 2034, reaching USD 95.65 billion by…

Cover Glass Market Size & Share | Growth Report - 2034
According to the report by Expert Market Research (EMR), the global cover glass market attained a value of USD 45.00 billion in 2024. Aided by the increasing demand for durable, scratch-resistant, and aesthetically appealing display panels across consumer electronics and automotive applications, the market is projected to grow at a CAGR of 3.50% between 2025 and 2034 to reach a value of nearly USD 63.48 billion by 2034.
Cover glass is…

Brain Monitoring Market to Reach USD 10.23 Bn by 2034
The global healthcare industry is rapidly advancing, with neurological diagnostics and monitoring gaining increasing attention. Among the core technologies enabling this evolution is brain monitoring, which plays a vital role in diagnosing conditions such as epilepsy, Parkinson's disease, and traumatic brain injuries. According to a recent report by Expert Market Research, the brain monitoring market reached a value of USD 5.40 billion in 2024. It is projected to expand at…

Cellulose Market Size & Share Report - 2034 | Industry Trends
According to the report by Expert Market Research (EMR), the global cellulose market is expected to witness steady growth over the forecast period of 2025-2034, expanding at a compound annual growth rate (CAGR) of 4.10%. The market is being driven by the increasing demand for sustainable and biodegradable materials across various end-use industries, including paper and pulp, textiles, pharmaceuticals, food and beverages, and personal care. With rising environmental concerns and…
More Releases for PMR
Starch Derivatives Market Outlook by 2021 : PMR
Starch derivatives, also known as modified starch, are prepared by enzymatically, physically or chemically treating native starch to alter its properties. Starch derivatives are used in a number of industries for various functions. They are used as thickeners and stabilizers in the food and beverage industry, as a tablet binder in the pharmaceutical industry, as an emulsifier in cosmetics, and fiber additive in the animal feed. Some of the other…
Yeast Ingredients Market Outlook by 2021 : PMR
Yeasts are chemoorganotrophs, as they use organic compounds to source energy and do not require sunlight for growth or survival. Yeasts are usually unicellular; although some species may be multi-cellular. The size of yeast depends on the species. Yeasts usually measure 3 to 4 µm in diameter. However, certain yeasts reach up to 40 µm in diameter. Yeasts reproduce asexually through mitosis (a process, in which, the chromosomes in a…
Confectionery Market Outlook by 2021 : PMR
The confectionery market is one of the growing sectors globally . Usually, confections are low in nutrients and high in calorie. Sugar-free confections are gaining popularity in the recent years due to factors such as increasing obesity rate, increasing number of diabetic patients, increasing nutritional and health concerns, and changing lifestyle. The confectionery market can be primarily divided into two broad categories: sugar confectionery and bakers’ confectionery . Sugar confectionery…
Cereal Bars Market Outlook by 2021 : PMR
A cereal bar is made up of nuts, oats, sugar, dry fruits, flour, honey, wheat, corn, and puffed rice. Cereal bars have always been perceived as on-the-go breakfast snack items that are healthier alternatives of chocolate and other snacks. Cereal bars are high in fiber and protein and low in carbohydrates, vitamins, minerals, sodium, and antioxidants. They come in various flavors such as chocolate, peanut butter, banana, caramel, banana, honey,…
Functional Flours Market Share by 2026 : PMR
The natural flours used for specialty applications in the food industry and undergoes different treatment process to improve their properties are called functional flours. The various properties of functional flours include cold binding capacity, thermal binding capacity, machinability, dough hydration etc. The functional flours are classified as waxy, multi-benefit, instant and granulated type depending on its features. They undergo different physical and nutritional treatment to enhance its features. In dietary…
Global Ceilings Market Snapshot by 2020 : PMR
Ceiling is overhead interior portion within the room which covers the upper portion of the room. Main purpose of ceiling is to achieve the desired height of the roof in the room. Ceilings are frequently decorated with attractive paintings, mosaic tiles and other different designs. Major advantage of decorated ceiling is that it gets protected from damage by fingers and dust. There are certain ceilings which are fire resistance; dropping…